Summary
Drug use continues to be a problem of major concern for public authorities worldwide. According to the World Drug Report elaborated by the United Nations Office of Drugs and Crime (UNODC) approximately 207,000 drug-related deaths occur per year. With between 162 million and 324 million people aged 15-64 having used an illicit drug — mainly substances belonging to canabinoids, opioids, cocaine or amphetamine-type stimulants group — at least once in the previous year, drug abuse continues to have devastating consequences on human health.
The methods currently used to identify illicit drugs, such as colour tests, lack selectivity, and need further confirmation by expensive and time consuming chromatography-mass spectrometry methods, thus it is imperative to develop new sensing technologies that allow a fast, sensitive and selective detection of illicit drugs.
This project proposes to develop novel, inexpensive and portable multisensing devices adapted for the rapid on-site screening of a number of illicit drugs, using recent advances in biomimetic materials coupled with electrochemistry. The multisensing devices will facilitate (1) detection and capturing illicit drugs crossing borders and (2) identification of drug users (e.g. drivers of vehicles at roadside, employees at work places, prisoners). In addition to rapidity and high selectivity of the detection, the sensing strategies will also give informations about (1) the type of drug and cutting agents (2) amount of drug present in biological samples. Moreover, the strategies employed will bring insights for better understanding of biomimicking nanoplatforms leading to more efficient technologies in health and biotech.
The achievement of the actions goal will lead to reducing the incidence and prevalence of illicit drugs use and to a better management of drug-related problems with high societal impact. The underlying technologies will open doors for a broader range of applications.
The methods currently used to identify illicit drugs, such as colour tests, lack selectivity, and need further confirmation by expensive and time consuming chromatography-mass spectrometry methods, thus it is imperative to develop new sensing technologies that allow a fast, sensitive and selective detection of illicit drugs.
This project proposes to develop novel, inexpensive and portable multisensing devices adapted for the rapid on-site screening of a number of illicit drugs, using recent advances in biomimetic materials coupled with electrochemistry. The multisensing devices will facilitate (1) detection and capturing illicit drugs crossing borders and (2) identification of drug users (e.g. drivers of vehicles at roadside, employees at work places, prisoners). In addition to rapidity and high selectivity of the detection, the sensing strategies will also give informations about (1) the type of drug and cutting agents (2) amount of drug present in biological samples. Moreover, the strategies employed will bring insights for better understanding of biomimicking nanoplatforms leading to more efficient technologies in health and biotech.
The achievement of the actions goal will lead to reducing the incidence and prevalence of illicit drugs use and to a better management of drug-related problems with high societal impact. The underlying technologies will open doors for a broader range of applications.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/753223 |
| Start date: | 01-05-2017 |
| End date: | 30-04-2019 |
| Total budget - Public funding: | 160 800,00 Euro - 160 800,00 Euro |
Cordis data
Original description
Drug use continues to be a problem of major concern for public authorities worldwide. According to the World Drug Report elaborated by the United Nations Office of Drugs and Crime (UNODC) approximately 207,000 drug-related deaths occur per year. With between 162 million and 324 million people aged 15-64 having used an illicit drug — mainly substances belonging to canabinoids, opioids, cocaine or amphetamine-type stimulants group — at least once in the previous year, drug abuse continues to have devastating consequences on human health.The methods currently used to identify illicit drugs, such as colour tests, lack selectivity, and need further confirmation by expensive and time consuming chromatography-mass spectrometry methods, thus it is imperative to develop new sensing technologies that allow a fast, sensitive and selective detection of illicit drugs.
This project proposes to develop novel, inexpensive and portable multisensing devices adapted for the rapid on-site screening of a number of illicit drugs, using recent advances in biomimetic materials coupled with electrochemistry. The multisensing devices will facilitate (1) detection and capturing illicit drugs crossing borders and (2) identification of drug users (e.g. drivers of vehicles at roadside, employees at work places, prisoners). In addition to rapidity and high selectivity of the detection, the sensing strategies will also give informations about (1) the type of drug and cutting agents (2) amount of drug present in biological samples. Moreover, the strategies employed will bring insights for better understanding of biomimicking nanoplatforms leading to more efficient technologies in health and biotech.
The achievement of the actions goal will lead to reducing the incidence and prevalence of illicit drugs use and to a better management of drug-related problems with high societal impact. The underlying technologies will open doors for a broader range of applications.
Status
CLOSEDCall topic
MSCA-IF-2016Update Date
28-04-2024
Geographical location(s)
